Discover
TERN
Terns Pharmaceuticals, Inc.
52.95
2 x 38.13
2 x 67.80
bid
ask
-
0.02
0.03%
2 @ 04:00 PM
52.97 +0.02 (0.04%)
| Ytd | 31.06% | |
| 1y | 1797.85% |
52.97
day range
52.97
2.65
52 week range
53.19
| Open | 52.97 | Prev Close | 52.97 | Low | 52.97 | High | 52.97 | Mkt Cap | 6.12B |
| Vol | 6.33M | Avg Vol | 5.92M | EPS | -1.03 | P/E | N/A | Forward P/E | -34.01 |
| Beta | -0.38 | Short Ratio | 0.70 | Inst. Own | 109.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 50.15 | 200-d Avg | 29.48 | 1yr Est | 53.00 |
| Income Statement | |||
| Operating Expenses | 27.60M | ||
| Research and Development Expense | 18.90M | ||
| Selling, General and Administrative Expense | 8.70M | ||
| Operating Income | -27.60M | ||
| Income Tax Expense | 383.00K | ||
| Net Income | -23.57M | ||
| Net Income Common Stock | -23.57M | ||
| Net Income Common Stock (USD) | -23.57M | ||
| Consolidated Income | -23.57M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -23.19M | ||
| Earning Before Interest & Taxes (USD) | -23.19M | ||
| Weighted Average Shares | 97.91M | ||
| Weighted Average Shares Diluted | 97.91M | ||
| Balance Sheet | |||
| Cash and Equivalents | 524.75M | ||
| Cash and Equivalents (USD) | 524.75M | ||
| Investments | 494.24M | ||
| Investments Current | 494.24M | ||
| Current Assets | 1.02B | ||
| Property, Plant & Equipment Net | 884.00K | ||
| Total Assets | 1.03B | ||
| Debt Current | 474.00K | ||
| Total Debt | 919.00K | ||
| Current Liabilities | 16.41M | ||
| Debt Non-Current | 445.00K | ||
| Total Liabilities | 18.55M | ||
| Accumulated Retained Earnings (Deficit) | -517.69M | ||
| Accumulated Other Comprehensive Income | 260.00K | ||
| Shareholders Equity | 1.01B | ||
| Shareholders Equity (USD) | 1.01B | ||
| Assets Non-Current | 884.00K | ||
| Total Debt (USD) | 919.00K | ||
| Liabilities Non-Current | 2.14M | ||
| Trade and Non-Trade Payables | 1.72M | ||
| Tax Liabilities | 1.70M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 113.00K | ||
| Net Cash Flow from Financing | 743.12M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 374.05M | ||
| Issuance (Purchase) of Equity Shares | 743.35M | ||
| Net Cash Flow from Investing | -350.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -350.00M | ||
| Net Cash Flow from Operations | -19.08M | ||
| Effect of Exchange Rate Changes on Cash | 15.00K | ||
| Share Based Compensation | 3.35M | ||